Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome
Patrick D McGorry, Barnaby Nelson, Lisa J Phillips, Hok Pan Yuen, Shona M Francey, Annette Thampi, Gregor E Berger, G Paul Amminger, Magenta B Simmons, Daniel Kelly, Andrew D Thompson, Alison R Yung
Journal of Clinical Psychiatry | PHYSICIANS POSTGRADUATE PRESS | Published : 2013
Dr McGorry has served as a consultant to Bristol-Myers Squibb, Eli Lilly, Pfizer, Roche, Lundbeck, AstraZeneca, Sanofi-Synthelabo, and Janssen-Cilag and has received unrestricted research funding from Janssen-Cilag, Bristol-Myers Squibb, and AstraZeneca. Drs Phillips and Yung have received unrestricted research grant funding from Janssen Cilag. Dr Thompson has received unrestricted research grant funding from Janssen Cilag, Pfizer, and AstraZeneca. Drs Nelson, Francey, Thampi, Berger, and Amminger; Messrs Yuen and Kelly; and Ms Simmons report no potential conflict of interest.